Cawachi Limited (TYO:2664)
2,710.00
+26.00 (0.97%)
Mar 6, 2025, 1:37 PM JST
Cawachi Revenue
Cawachi had revenue of 69.62B JPY in the quarter ending December 15, 2024, a decrease of -0.40%. This brings the company's revenue in the last twelve months to 287.13B, up 0.67% year-over-year. In the fiscal year ending March 15, 2024, Cawachi had annual revenue of 285.96B with 1.45% growth.
Revenue (ttm)
287.13B
Revenue Growth
+0.67%
P/S Ratio
0.22
Revenue / Employee
105.48M
Employees
2,722
Market Cap
61.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 15, 2024 | 285.96B | 4.09B | 1.45% |
Mar 15, 2023 | 281.87B | 2.41B | 0.86% |
Mar 15, 2022 | 279.46B | -5.03B | -1.77% |
Mar 15, 2021 | 284.49B | 14.18B | 5.25% |
Mar 15, 2020 | 270.31B | 5.39B | 2.03% |
Mar 15, 2019 | Pro | Pro | Pro |
Mar 15, 2018 | Pro | Pro | Pro |
Mar 15, 2017 | Pro | Pro | Pro |
Mar 15, 2016 | Pro | Pro | Pro |
Mar 15, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Otsuka Holdings | 2,329.86B |
Terumo | 1,011.15B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |